Evolving Therapeutic Paradigms for Advanced Prostate CancerByJoshua M. Ruch, MD,Maha H. Hussain, MDMay 15th 2011This review will discuss recently FDA-approved agents for advanced prostate cancer and those under investigation in phase III trials.